|
SNRK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.376400E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.020300E-03 |
| Normal-vs-Stage2 |
1.158380E-02 |
| Normal-vs-Stage3 |
2.090499999996E-05 |
| Normal-vs-Stage4 |
2.837400E-04 |
| Stage1-vs-Stage2 |
8.427800E-01 |
| Stage1-vs-Stage3 |
1.228160E-01 |
| Stage1-vs-Stage4 |
6.731900E-02 |
| Stage2-vs-Stage3 |
2.585600E-01 |
| Stage2-vs-Stage4 |
2.097800E-01 |
| Stage3-vs-Stage4 |
5.874200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.34630000000613E-05 |
| Normal-vs-AfricanAmerican |
4.279600E-02 |
| Normal-vs-Asian |
2.757500E-03 |
| Caucasian-vs-AfricanAmerican |
1.131450E-01 |
| Caucasian-vs-Asian |
2.096600E-01 |
| AfricanAmerican-vs-Asian |
2.052200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8645999999567E-06 |
| Normal-vs-Female |
3.492800E-01 |
| Male-vs-Female |
5.805700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.964200E-02 |
| Normal-vs-Extreme_Weight |
1.284510E-03 |
| Normal-vs-Obese |
1.839460E-03 |
| Normal-vs-Extreme_Obese |
5.322400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.811200E-01 |
| Normal_Weight-vs-Obese |
7.348400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.658200E-01 |
| Extreme_Weight-vs-Obese |
6.009400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.765400E-01 |
| Obese-vs-Extreme_Obese |
3.607000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.283200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.574200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.61909999962795E-07 |
| Normal-vs-Age(81-100Yrs) |
2.594000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.997200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.942600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.481800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.361700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.014300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.200000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.276300E-03 |
| Normal-VS-Type2 PRCC |
3.696700000555E-07 |
| Normal-VS-KIRP CIMP |
1.6425000026743E-08 |
| Normal-VS-Unclassified PRCC |
1.75810999999415E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.175800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.784320E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.650300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.685900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.843000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.841570E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22619999989959E-07 |
| Normal-vs-N1 |
6.45119999642674E-08 |
| Normal-vs-N2 |
8.688000E-02 |
| N0-vs-N1 |
5.880000E-01 |
| N0-vs-N2 |
4.660400E-01 |
| N1-vs-N2 |
4.942200E-01 |
|
|
